Albion Laboratories Inc. and Alora Pharmaceuticals LLC’s Avion unit allege that
Balcoltra, an oral contraceptive used by women to prevent pregnancy, is supplied as levonorgestrel and ethinyl estradiol tablets, and ferrous bisglycinate tablets, according to a complaint Albion and Avion filed Thursday in the US District Court for the District of Delaware.
The patent, which covers compositions of hypoallergenic metal amino acid chelates and methods of preparing and administering ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
